Gordon K. Norman, MD, MBA. Author reply by Soeren Mattke, MD, DSc
Advertisement
Articles by Gordon K. Norman, MD, MBA. Author reply by Soeren Mattke, MD, DSc
Advertisement
Latest Updated Articles
- All Things Considered, the Answer Is a Resounding Yes
Published: January 15th 2008 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Cefdinir Nearly Doubles Outpatient Uncomplicated UTI Treatment Failure Compared With Cephalexin
2
FDA Approves Ziftomenib for R/R NPM1-Mutated AML
3
Nipocalimab Investigation Extends to Younger Patients: Jonathan Strober, MD
4
Managed Care Reflections: A Q&A With Laurie C. Zephyrin, MD, MPH, MBA
5
